Katie Coupe, Astrid Block, Sueann Mark, Bruce A Cooper, Steven M Paul, Laura B Dunn, Marilyn J Hammer, Yvette P Conley, Jon D Levine, Christine Miaskowski
{"title":"压力和童年不良经历的增加与肿瘤患者同时出现焦虑和抑郁有关。","authors":"Katie Coupe, Astrid Block, Sueann Mark, Bruce A Cooper, Steven M Paul, Laura B Dunn, Marilyn J Hammer, Yvette P Conley, Jon D Levine, Christine Miaskowski","doi":"10.1080/07347332.2024.2326146","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Identify subgroups of patients with distinct joint anxiety AND depression profiles and evaluate for differences in demographic and clinical characteristics, as well as stress, resilience, and coping.</p><p><strong>Design: </strong>Longitudinal study.</p><p><strong>Participants: </strong>Patients (<i>n</i> = 1328) receiving chemotherapy.</p><p><strong>Methods: </strong>Measures of state anxiety and depression were done six times over two cycles of chemotherapy. All of the other measures were completed prior to second or third cycle of chemotherapy. Latent profile analysis was used to identify the distinct joint anxiety and depression profiles.</p><p><strong>Findings: </strong>Three classes were identified (i.e. Low Anxiety and Low Depression (57.5%); Moderate Anxiety and Moderate Depression (33.7%), High Anxiety and High Depression (8.8%)). For all of the stress measures, a dose response effect was seen among the profiles. Two worst profiles reported higher occurrence rates for a number of adverse childhood experiences.</p><p><strong>Implications for providers: </strong>Patients need referrals for stress reduction techniques and mental health and social services.</p>","PeriodicalId":47451,"journal":{"name":"Journal of Psychosocial Oncology","volume":" ","pages":"769-792"},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11422520/pdf/","citationCount":"0","resultStr":"{\"title\":\"Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients.\",\"authors\":\"Katie Coupe, Astrid Block, Sueann Mark, Bruce A Cooper, Steven M Paul, Laura B Dunn, Marilyn J Hammer, Yvette P Conley, Jon D Levine, Christine Miaskowski\",\"doi\":\"10.1080/07347332.2024.2326146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Identify subgroups of patients with distinct joint anxiety AND depression profiles and evaluate for differences in demographic and clinical characteristics, as well as stress, resilience, and coping.</p><p><strong>Design: </strong>Longitudinal study.</p><p><strong>Participants: </strong>Patients (<i>n</i> = 1328) receiving chemotherapy.</p><p><strong>Methods: </strong>Measures of state anxiety and depression were done six times over two cycles of chemotherapy. All of the other measures were completed prior to second or third cycle of chemotherapy. Latent profile analysis was used to identify the distinct joint anxiety and depression profiles.</p><p><strong>Findings: </strong>Three classes were identified (i.e. Low Anxiety and Low Depression (57.5%); Moderate Anxiety and Moderate Depression (33.7%), High Anxiety and High Depression (8.8%)). For all of the stress measures, a dose response effect was seen among the profiles. Two worst profiles reported higher occurrence rates for a number of adverse childhood experiences.</p><p><strong>Implications for providers: </strong>Patients need referrals for stress reduction techniques and mental health and social services.</p>\",\"PeriodicalId\":47451,\"journal\":{\"name\":\"Journal of Psychosocial Oncology\",\"volume\":\" \",\"pages\":\"769-792\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11422520/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Psychosocial Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/07347332.2024.2326146\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHOLOGY, SOCIAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychosocial Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/07347332.2024.2326146","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/25 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PSYCHOLOGY, SOCIAL","Score":null,"Total":0}
Increases in stress and adverse childhood experiences are associated with the co-occurrence of anxiety and depression in oncology patients.
Purpose: Identify subgroups of patients with distinct joint anxiety AND depression profiles and evaluate for differences in demographic and clinical characteristics, as well as stress, resilience, and coping.
Methods: Measures of state anxiety and depression were done six times over two cycles of chemotherapy. All of the other measures were completed prior to second or third cycle of chemotherapy. Latent profile analysis was used to identify the distinct joint anxiety and depression profiles.
Findings: Three classes were identified (i.e. Low Anxiety and Low Depression (57.5%); Moderate Anxiety and Moderate Depression (33.7%), High Anxiety and High Depression (8.8%)). For all of the stress measures, a dose response effect was seen among the profiles. Two worst profiles reported higher occurrence rates for a number of adverse childhood experiences.
Implications for providers: Patients need referrals for stress reduction techniques and mental health and social services.
期刊介绍：
Here is your single source of integrated information on providing the best psychosocial care possible from the knowledge available from many disciplines.The Journal of Psychosocial Oncology is an essential source for up-to-date clinical and research material geared toward health professionals who provide psychosocial services to cancer patients, their families, and their caregivers. The journal—the first interdisciplinary resource of its kind—is in its third decade of examining exploratory and hypothesis testing and presenting program evaluation research on critical areas, including: the stigma of cancer; employment and personal problems facing cancer patients; patient education.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
